Charles Stark
Förmögenhet: 1 091 $ per 2026-08-31
Förmögenhet: 1 091 $ per 2026-08-31
Dr. Charles W.
Stark is a Senior Vice President-Medical Affairs at EMI Holding, Inc. and a Chief Science Officer & EVP-Clinical Development at Emmaus Life Sciences, Inc. He is on the Board of Directors at St. Mary's Regional Medical Center (Oklahoma).
Dr. Stark was previously employed as a Director-Clinical Development by Bavarian Nordic A/S, an Associate Director-Medical Affairs by Dendreon Corp., a Director-Investigational Drug Services by Harbor-UCLA Medical Center, a Director-Investigational Drug Services by Health Research Association, Inc., a Director-Investigational Drug Services by Los Angeles Biomedical Research Institute at Harbor-UCLA, a Director-Investigational Drug Services by Los Angeles County+USC Medical Center, and a Director-Medical Science Liaisons by Pfizer Inc. He received his doctorate degree from the University of Southern California.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-03-15 | 18 182 ( 0,03 % ) | 1 091 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-07-19 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Teknisk/Vetenskaplig/F&U Direktör | 2013-11-01 |
St. Mary's Regional Medical Center (Oklahoma)
St. Mary's Regional Medical Center (Oklahoma) Hospital/Nursing ManagementHealth Services Operates a hospital | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
Health Research Association, Inc. | Företagsledare/Principal | - |
Los Angeles County+USC Medical Center | Företagsledare/Principal | - |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Företagsledare/Principal | - |
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Operates as biomedical research organization | Företagsledare/Principal | - |
| PFIZER INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Operates as biomedical research organization | Health Technology |
Health Research Association, Inc. | |
St. Mary's Regional Medical Center (Oklahoma)
St. Mary's Regional Medical Center (Oklahoma) Hospital/Nursing ManagementHealth Services Operates a hospital | Health Services |
Los Angeles County+USC Medical Center | |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Health Services |
Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån